Personalis (PSNL) Cash & Current Investments (2017 - 2026)
Personalis (PSNL) recorded quarterly Cash & Current Investments of $233.2 million in Q1 2026, down 2.81% quarter-over-quarter from $240.0 million in Q4 2025, and up 25.6% on a YoY basis from $185.7 million in Q1 2025.
Personalis (PSNL) Cash & Current Investments (2017 - 2026) Analysis & Trends
Personalis' Cash & Current Investments history runs 10 years deep, the most recent figure standing at $233.2 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 25.6% year-over-year to $233.2 million; the TTM figure through Mar 2026 stood at $233.2 million (up 25.6% YoY), while the FY2025 annual figure was $240.0 million, up 29.7% from the prior year.
- Cash & Current Investments was $233.2 million for Q1 2026 at Personalis, down from $240.0 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $266.5 million in Q1 2022 to a low of $87.0 million in Q2 2024.
- Historically, Cash & Current Investments has averaged $169.1 million across 5 years, with a median of $167.7 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Cash & Current Investments sank 44.12% in 2023, then soared 99.18% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $167.7 million in 2022, then slumped by 31.9% to $114.2 million in 2023, then surged by 62.03% to $185.0 million in 2024, then gained by 29.7% to $240.0 million in 2025, then fell by 2.81% to $233.2 million in 2026.
- The last three Cash & Current Investments figures came in at $233.2 million (Q1 2026), $240.0 million (Q4 2025), and $150.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 462.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 3.26 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 5.70 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 200.53 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 1.81 Bn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 2.10 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 1.10 Bn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 1.16 Bn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 60.60 Mn |
| 10 | Personalis | 1.00 Bn | 768.07 Mn | 281,000.00 | 233.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 233.22 Mn |
| Dec 31, 2025 | 239.95 Mn |
| Sep 30, 2025 | 150.52 Mn |
| Jun 30, 2025 | 173.23 Mn |
| Mar 31, 2025 | 185.69 Mn |
| Dec 31, 2024 | 185.01 Mn |
| Sep 30, 2024 | 143.65 Mn |
| Jun 30, 2024 | 86.97 Mn |
| Mar 31, 2024 | 95.42 Mn |
| Dec 31, 2023 | 114.18 Mn |
| Sep 30, 2023 | 120.66 Mn |
| Jun 30, 2023 | 137.21 Mn |
| Mar 31, 2023 | 148.94 Mn |
| Dec 31, 2022 | 167.66 Mn |
| Sep 30, 2022 | 192.76 Mn |
| Jun 30, 2022 | 233.49 Mn |
| Mar 31, 2022 | 266.54 Mn |
| Dec 31, 2021 | 287.06 Mn |
| Sep 30, 2021 | 305.23 Mn |
| Jun 30, 2021 | 328.91 Mn |